Pasithea Therapeutics (KTTA) Shares Outstanding (2020 - 2026)

Pasithea Therapeutics' Shares Outstanding history runs 7 years deep, the most recent figure standing at $24.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 821.9% year-over-year to $24.9 million; the TTM figure through Mar 2026 stood at $24.9 million (up 821.9% YoY), while the FY2025 annual figure was $23.1 million, up 1556.15% from the prior year.
• Shares Outstanding came in at $24.9 million for Q1 2026 at Pasithea Therapeutics, up from $23.1 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $26.5 million in Q2 2022 to a low of $1.0 million in Q3 2023.
• A 5-year average of $9.0 million and a median of $1.4 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding slumped 96.08% in 2023 and jumped 1556.15% in 2025, its largest moves.
• Pasithea Therapeutics' Shares Outstanding stood at $1.3 million in 2022, then slipped by 20.0% to $1.0 million in 2023, then jumped by 33.86% to $1.4 million in 2024, then surged by 1556.15% to $23.1 million in 2025, then climbed by 8.01% to $24.9 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $24.9 million, $23.1 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison